Urinary tract infections.

Area of Science:

• Urology
• Health Economics
• Pharmacoeconomics

Background:

• Urinary tract infections (UTIs) are common, particularly among women aged 18-64.
• Understanding healthcare utilization and costs associated with UTIs is crucial for health plan management.

Purpose of the Study:

• To analyze healthcare resource utilization and prescribing patterns for uncomplicated UTIs in adult women.
• To identify potential cost savings through adherence to clinical prescribing guidelines.

Main Methods:

• Retrospective analysis of healthcare claims data for women aged 18-64 with uncomplicated UTIs.
• Evaluation of office visits, prescriptions, laboratory services, and pharmaceutical therapies.

Main Results:

• Patients averaged 1.07 office visits, 2.36 prescriptions, and 2.34 laboratory services per patient-treated episode (PTE).
• Approximately 71% of PTEs received pharmaceutical therapy, accounting for 31% of total UTI charges.
• Trimethoprim/sulfamethoxazole and fluoroquinolones were common single-drug treatments.

Conclusions:

• Uncomplicated UTI treatment in adult women involves moderate healthcare resource use, with significant pharmaceutical expenditure.
• Physician prescribing patterns warrant further investigation to promote guideline adherence and reduce healthcare costs.